Entyvio 300 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FKKE3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $97,614
Award facts
- Contract value 100% obligated
- $97,613.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $97,613.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of ENTYVIO 300 mg vials. The delivery order, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, carries no set-aside designation, indicating the award was made through full and open competition. DMS Pharmaceutical Group is performing the work at its Park Ridge facility and will deliver this specialty pharmaceutical product to support Department of Defense medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy supporting recurring medical supply needs across military healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, establishes DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables through firm fixed-price delivery orders through December 31, 2036. The company's established performance across numerous prior pharmaceutical delivery orders demonstrates its capability to fulfill the specialized requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FKKE3?
SPE2DR26FKKE3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FKKE3 worth?
The government has obligated $97,614 on SPE2DR26FKKE3.
Is contract SPE2DR26FKKE3 an order under another contract?
Yes. SPE2DR26FKKE3 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKE3 competed?
The extent of competition for SPE2DR26FKKE3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award